2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
10
Colonic Neoplasms
9
Prostatic Neoplasms
8
Colorectal Neoplasms
6
Neoplasms
5
Multiple Myeloma
4
Uterine Cervical Neoplasms
3
Stomach Neoplasms
3
Smoldering Multiple Myeloma
3
Rectal Neoplasms
3
Pancreatic Neoplasms
3
Monoclonal Gammopathy of Undetermined Significance
3
Lung Neoplasms
3
Adenomatous Polyposis Coli
3
Uterine Cervical Dysplasia
2
Radiodermatitis
2
Pain
2
Esophageal Neoplasms
2
Breast Carcinoma In Situ
2
cyclopia sequence
1
Uterine Neoplasms
1
Tuberous Sclerosis
1
Thrombocythemia, Essential
1
Stomatitis
1
Sezary Syndrome
1
Seizures
1
Psychological Well-Being
1
Prostate Cancer Metastatic Castration Resistant
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
Paclitaxel
13
pembrolizumab
8
Carboplatin
7
Surveys and Questionnaires
6
Cisplatin
6
Brachytherapy
5
Doxorubicin
4
Docetaxel
4
Pemetrexed
3
Hyperthermic Intraperitoneal Chemotherapy
3
Gemcitabine
3
FANG vaccine
3
Biopsy
3
osimertinib
2
olaparib
2
niraparib
2
durvalumab
2
adavosertib
2
Trastuzumab
2
Topotecan
2
Taxes
2
Standard of Care
2
Sentinel Lymph Node Biopsy
2
Saline Solution
2
Radiotherapy, Intensity-Modulated
2
Radiotherapy
2
Radiation
2
Oxaliplatin
2
Nivolumab
2
Music Therapy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Neoplasms
×
Curcumin
×
Clear all
NCT03192059
2021-09-08
PRIMMO
University Hospital, Ghent
Phase 2
Completed
43 enrolled